The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Open accessAbstract
IDSA/ATS Guidelines for CAP in Adults • CID 2007:44 (Suppl 2) • S31 33.A longer duration of therapy may be needed if initial therapy was not active against the identified pathogen or if it was complicated by extrapulmonary infection, such as meningitis or endocarditis.(Weak recommendation; level III evidence.)Other Treatment Considerations 34.Patients with CAP who have persistent septic shock despite adequate fluid resuscitation should be considered for treatment with drotrecogin alfa activated within 24 h of admission.(Weak recommendation; level II evidence.)35.Hypotensive, fluid-resuscitated patients with severe CAP should be screened for occult adrenal insufficiency.(Moderate recommendation; level II evidence.)36.Patients with hypoxemia or respiratory distress should receive a cautious trial of noninvasive ventilation unless they require immediate intubation because of severe hypoxemia (PaO 2 /FiO 2 ratio, !150) and bilateral alveolar infiltrates.(Moderate recommendation; level I evidence.)37. Low-tidal-volume ventilation (6 cm 3 /kg of ideal body weight) should be used for patients undergoing ventilation who have diffuse bilateral pneumonia or acute respiratory distress syndrome.(Strong recommendation; level I evidence.)Management of Nonresponding Pneumonia Definitions and classification.38.The use of a systematic classification of possible causes of failure to respond, based on time of onset and type of failure (table 11), is recommended.(Moderate recommendation; level II evidence.)As many as 15% of patients with CAP may not respond appropriately to initial antibiotic therapy.A systematic approach to these patients (table 11) will help to determine the cause.Because determination of the cause of failure is more accurate if the original microbiological etiology is known, risk factors for nonresponse or deterioration (table 12) figure prominently in the list of situations in which more aggressive and/ or extensive initial diagnostic testing is warranted (table 5).Prevention (see table 13) 39.All persons у50 years of age, others at risk for influenza complications, household contacts of high-risk persons, and health care workers should receive inactivated influenza vaccine as recommended by the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention.(Strong recommendation; level I evidence.)40.The intranasally administered live attenuated vaccine is an alternative vaccine formulation for some persons 5-49 years of age without chronic underlying diseases, including immunodeficiency, asthma, or chronic medical conditions.(Strong recommendation; level I evidence.)41.Health care workers in inpatient and outpatient settings and long-term care facilities should receive annual influenza immunization.(Strong recommendation; level I evidence.)42.Pneumococcal polysaccharide vaccine is recommended for persons у65 years of age and for those with selected high-risk concurrent diseases, according to current Advisory Committee on Immunization Practices guidelines.(Strong recommendation; level II evidence.)43.Vaccination status should be assessed at the time of hospital admission for all patients, especially those with medical illnesses.(Moderate recommendation; level III evidence.)44.Vaccination may be performed either at hospital discharge or during outpatient treatment.(Moderate recommendation; level III evidence.)45.Influenza vaccine should be offered to persons at hospital discharge or during outpatient treatment during the fall and winter.(Strong recommendation; level III evidence.)46.Smoking cessation should be a goal for persons hospitalized with CAP who smoke.(Moderate recommendation; level III evidence.)47.Smokers who will not quit should also be vaccinated for both pneumococcus and influenza.(Weak recommendation; level III evidence.)48.Cases of pneumonia that are of public health concern should be reported immediately to the state or local health department.(Strong recommendation; level III evidence.)49.Respiratory hygiene measures, including the use of hand hygiene and masks or tissues for patients with cough, should be used in outpatient settings and EDs as a means to reduce the spread of respiratory infections.(Strong recommendation; level III evidence.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999) · JAMA · doi:10.1001/jama.282.15.1458 · Cited by 6,677
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Cited by
Items 101–171 of 171
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir625 · Cited by 298
Community-acquired Pneumonia and Hospital-acquired Pneumonia
Lanks, C. W., Musani, A. I., & Hsia, D. W. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.008 · Cited by 297
Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study
MacFadden, D. R., LaDelfa, A., Leen, J., Gold, W. L., Daneman, N., Weber, E., Al-Busaidi, I., Petrescu, D., Saltzman, I., Devlin, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw462 · Cited by 296
Snijders, D., Daniels, J. M. A., de Graaff, C. S., van der Werf, T. S., & Boersma, W. G. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0808oc · Cited by 295
Venditti, M., Falcone, M., Corrao, S., Licata, G., Serra, P., & the Study Group of the Italian Society of Internal Medicine* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00005 · Cited by 294
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & De Giorgio, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 294
Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation
Ahmad, V., Khan, M. S., Jamal, Q. M. S., Alzohairy, M. A., Al Karaawi, M. A., & Siddiqui, M. U. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.016 · Cited by 293
Metersky, M. L., Masterton, R. G., Lode, H., File, T. M., & Babinchak, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.01.003 · Cited by 293
Self-citationRisk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia
Shindo, Y., Ito, R., Kobayashi, D., Ando, M., Ichikawa, M., Shiraki, A., Goto, Y., Fukui, Y., Iwaki, M., Okumura, J., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0079oc · Cited by 292
Liu, Y.-N., Zhang, Y.-F., Xu, Q., Qiu, Y., Lu, Q.-B., Wang, T., Zhang, X.-A., Lin, S.-H., Lv, C.-L., Jiang, B.-G., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00031-9 · Cited by 291
Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
Cilloniz, C., Martin-Loeches, I., Garcia-Vidal, C., San Jose, A., & Torres, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122120 · Cited by 291
Self-citationUranga, A., España, P. P., Bilbao, A., Quintana, J. M., Arriaga, I., Intxausti, M., Lobo, J. L., Tomás, L., Camino, J., Nuñez, J., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3633 · Cited by 290
Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention
Brooks, L. R. K., & Mias, G. I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01366 · Cited by 286
Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia
Johnstone, J., Majumdar, S. R., Fox, J. D., & Marrie, T. J. (2008) · Chest · doi:10.1378/chest.08-0888 · Cited by 285
Klehmet, J., Harms, H., Richter, M., Prass, K., Volk, H. D., Dirnagl, U., Meisel, A., & Meisel, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.044 · Cited by 281
Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia
Christ-Crain, M., Stolz, D., Jutla, S., Couppis, O., Müller, C., Bingisser, R., Schuetz, P., Tamm, M., Edwards, R., Müller, B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-307oc · Cited by 281
Discovery and development of safe-in-man broad-spectrum antiviral agents
Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.018 · Cited by 280
Bundled care for septic shock: An analysis of clinical trials*
Barochia, A. V., Cui, X., Vitberg, D., Suffredini, A. F., OʼGrady, N. P., Banks, S. M., Minneci, P., Kern, S. J., Danner, R. L., Natanson, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0ddf · Cited by 279
Park, J. H., Romero, F. A., Taur, Y., Sadelain, M., Brentjens, R. J., Hohl, T. M., & Seo, S. K. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy152 · Cited by 276
Pneumonia Due to Pseudomonas aeruginosa
Fujitani, S., Sun, H.-Y., Yu, V. L., & Weingarten, J. A. (2011) · Chest · doi:10.1378/chest.10-0166 · Cited by 273
Self, W. H., Williams, D. J., Zhu, Y., Ampofo, K., Pavia, A. T., Chappell, J. D., Hymas, W. C., Stockmann, C., Bramley, A. M., Schneider, E., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv323 · Cited by 273
Etiology of community-acquired pneumonia in adults: a systematic review
Shoar, S., & Musher, D. M. (2020) · Pneumonia · doi:10.1186/s41479-020-00074-3 · Cited by 273
Self-citationBalsamo, G., Maxted, A. M., Midla, J. W., Murphy, J. M., Wohrle, R., Edling, T. M., Fish, P. H., Flammer, K., Hyde, D., Kutty, P. K., et al. (2017) · Journal of Avian Medicine and Surgery · doi:10.1647/217-265 · Cited by 272
Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis
Kamat, I. S., Ramachandran, V., Eswaran, H., Guffey, D., & Musher, D. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz545 · Cited by 272
Self-citationStern, A., Skalsky, K., Avni, T., Carrara, E., Leibovici, L., & Paul, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007720.pub3 · Cited by 271
IPINet Investigators, Quinti, I., Soresina, A., Guerra, A., Rondelli, R., Spadaro, G., Agostini, C., Milito, C., Trombetta, A. C., Visentini, M., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9511-0 · Cited by 270
Murphy, C. N., Fowler, R., Balada-Llasat, J. M., Carroll, A., Stone, H., Akerele, O., Buchan, B., Windham, S., Hopp, A., Ronen, S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-20 · Cited by 269
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Wunderink, R. G., & Waterer, G. W. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1214869 · Cited by 267
Self-citationRationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Efficacy and safety of cefepime: a systematic review and meta-analysis
Yahav, D., Paul, M., Fraser, A., Sarid, N., & Leibovici, L. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70109-3 · Cited by 265
Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia
Müller, F., Christ-Crain, M., Bregenzer, T., Krause, M., Zimmerli, W., Mueller, B., & Schuetz, P. (2010) · Chest · doi:10.1378/chest.09-2920 · Cited by 259
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
Self, W. H., Balk, R. A., Grijalva, C. G., Williams, D. J., Zhu, Y., Anderson, E. J., Waterer, G. W., Courtney, D. M., Bramley, A. M., Trabue, C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix317 · Cited by 257
Self-citationHealth-Care-Associated Pneumonia Among Hospitalized Patients in a Japanese Community Hospital
Shindo, Y., Sato, S., Maruyama, E., Ohashi, T., Ogawa, M., Hashimoto, N., Imaizumi, K., Sato, T., & Hasegawa, Y. (2009) · Chest · doi:10.1378/chest.08-1357 · Cited by 257
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
Christ-Crain, M., Morgenthaler, N. G., Stolz, D., Müller, C., Bingisser, R., Harbarth, S., Tamm, M., Struck, J., Bergmann, A., & Müller, B. (2006) · Critical Care · doi:10.1186/cc4955 · Cited by 257
Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly
Almirall, J., Rofes, L., Serra-Prat, M., Icart, R., Palomera, E., Arreola, V., & Clavé, P. (2013) · European Respiratory Journal · doi:10.1183/09031936.00019012 · Cited by 255
Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
Ferreira-Coimbra, J., Sarda, C., & Rello, J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01248-7 · Cited by 255
Martin-Loeches, I., Lisboa, T., Rodriguez, A., Putensen, C., Annane, D., Garnacho-Montero, J., Restrepo, M. I., & Rello, J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1730-y · Cited by 254
Vaughn, V. M., Flanders, S. A., Snyder, A., Conlon, A., Rogers, M. A. M., Malani, A. N., McLaughlin, E., Bloemers, S., Srinivasan, A., Nagel, J., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3640 · Cited by 247
Critically Ill Children During the 2009–2010 Influenza Pandemic in the United States
Randolph, A. G., Vaughn, F., Sullivan, R., Rubinson, L., Thompson, B. T., Yoon, G., Smoot, E., Rice, T. W., Loftis, L. L., Helfaer, M., et al. (2011) · Pediatrics · doi:10.1542/peds.2011-0774 · Cited by 222
Martín-Loeches, I., Sanchez-Corral, A., Diaz, E., Granada, R. M., Zaragoza, R., Villavicencio, C., Albaya, A., Cerdá, E., Catalán, R. M., Luque, P., et al. (2011) · Chest · doi:10.1378/chest.10-1396 · Cited by 203
Smoking and the outcome of infection: Review: Smoking and infection
Huttunen, R., Heikkinen, T., & Syrjänen, J. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02332.x · Cited by 194
Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis
Havey, T. C., Fowler, R. A., & Daneman, N. (2011) · Critical Care · doi:10.1186/cc10545 · Cited by 187
Aliberti, S., Reyes, L. F., Faverio, P., Sotgiu, G., Dore, S., Rodriguez, A. H., Soni, N. J., Restrepo, M. I., Aruj, P. K., Attorri, S., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30267-5 · Cited by 179
Self-citationBroad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: A cohort study.
Webb, B. J., Sorensen, J., Jephson, A., Mecham, I., & Dean, N. C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00057-2019 · Cited by 164
Self-citationThabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.993381 · Cited by 160
Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia: A Meta-Analysis
Dimopoulos, G., Matthaiou, D. K., Karageorgopoulos, D. E., Grammatikos, A. P., Athanassa, Z., & Falagas, M. E. (2008) · Drugs · doi:10.2165/00003495-200868130-00004 · Cited by 160
Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis
SAMOKHVALOV, A. V., IRVING, H. M., & REHM, J. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810000774 · Cited by 159
(2015) · doi:10.1016/j.jinf.2014.10.004 · Cited by 143
Hanretty, A. M., & Gallagher, J. C. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2118 · Cited by 123
Jones, B. E., Ying, J., Stevens, V., Haroldsen, C., He, T., Nevers, M., Christensen, M. A., Nelson, R. E., Stoddard, G. J., Sauer, B. C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.7495 · Cited by 122
Repertoire of intensive care unit pneumonia microbiota
Bousbia, S., Papazian, L., Saux, P., Forel, J. M., Auffray, J.-P., Martin, C., Raoult, D., & La Scola, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032486 · Cited by 118
The impact of bacterial and viral co‐infection in severe influenza
Blyth, C. C., Webb, S. A. R., Kok, J., Dwyer, D. E., van Hal, S. J., Foo, H., Ginn, A. N., Kesson, A. M., Seppelt, I., Iredell, J. R., et al. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2012.00360.x · Cited by 117
“28, 29 Provision of cover against MRSA is recommended in those admitted to ICU, with necrotising ⁄ cavitatory infiltrates, empyema or microscopy demonstrating Gram-positive cocci in clusters in a respiratory specimen.”
BackgroundImplementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital.
du Plessis, T., Walls, G., Jordan, A., & Holland, D. J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky575 · Cited by 117
Chen, J. H., Alagappan, M., Goldstein, M. K., Asch, S. M., & Altman, R. B. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.03.006 · Cited by 101
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
Cillóniz, C., Ewig, S., Menéndez, R., Ferrer, M., Polverino, E., Reyes, S., Gabarrús, A., Marcos, M. A., Cordoba, J., Mensa, J., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.04.009 · Cited by 94
Self-citation(2014) · doi:10.1097/mcc.0000000000000124 · Cited by 89
Comprehensive quality of discharge summaries at an academic medical center
Horwitz, L. I., Jenq, G. Y., Brewster, U. C., Chen, C., Kanade, S., Van Ness, P. H., Araujo, K. L. B., Ziaeian, B., Moriarty, J. P., Fogerty, R. L., et al. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2021 · Cited by 86
Top 10 pearls for the recognition, evaluation, and management of maternal sepsis
Shields, A., de Assis, V., & Halscott, T. (2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004471 · Cited by 76
Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Tessmer, A., Welte, T., Schmidt-Ott, R., Eberle, S., Barten, G., Suttorp, N., & Schaberg, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00133510 · Cited by 65
Disease Severity in Patients with Simultaneous Influenza and Bacterial Pneumonia
Seki, M., Kosai, K., Yanagihara, K., Higashiyama, Y., Kurihara, S., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Tashiro, T., & Kohno, S. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6364 · Cited by 57
Linder, J. A., Kaleba, E. O., & Kmetik, K. S. (2009) · Medical Care · doi:10.1097/mlr.0b013e318189375f · Cited by 45
Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia
Achouiti, A., Vogl, T., Endeman, H., Mortensen, B. L., Laterre, P.-F., Wittebole, X., van Zoelen, M. A. D., Zhang, Y., Hoogerwerf, J. J., Florquin, S., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205668 · Cited by 39
(2010) · PubMed · Cited by 36
Cheng, V. C. C., Lau, Y.-K., Lee, K.-L., Yiu, K.-H., Chan, K.-H., Ho, P.-L., & Yuen, K.-Y. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.08.021 · Cited by 32
Bjarnason, A., Thorleifsdottir, G., Löve, A., Gudnason, J. F., Asgeirsson, H., Hallgrimsson, K. L., Kristjansdottir, B. S., Haraldsson, G., Baldursson, O., Kristinsson, K. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046816 · Cited by 30
(2010) · PubMed · Cited by 27
Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
Hsu, S.-C., Chang, J.-H., Hsu, Y.-P., Bai, K.-J., Huang, S.-K., & Hsu, C.-W. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216963 · Cited by 23
Griffin, A. T., Peyrani, P., Wiemken, T. L., Ramirez, J. A., & Arnold, F. W. (2013) · Infection · doi:10.1007/s15010-012-0363-1 · Cited by 17
Oshitani, Y., Nagai, H., & Matsui, H. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12054 · Cited by 12
Furlan, L., Erba, L., Trombetta, L., Sacco, R., Colombo, G., Casazza, G., Solbiati, M., Montano, N., Marta, C., Sbrojavacca, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1955-2 · Cited by 9
Metadata
- Authors
- Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., Torres, A., & Whitney, C. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 44
- Issue
- Supplement_2
- Pages
- S27-S72
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2133979383
- Cited by
- 6,202
- References
- 271
- FWCI
- 213.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.